Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?

Cardiovascular mortality is a major cause of death among in type 2 diabetes (T2DM). Endothelial dysfunction (ED) is a well-known important risk factor for the development of diabetes cardiovascular complications. Therefore, the prevention of diabetic macroangiopathies by preserving endothelial funct...

Full description

Bibliographic Details
Main Authors: Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Alfredo Caturano, Erica Vetrano, Concetta Aprea, Gaetana Albanese, Anna Di Martino, Carmen Ricozzi, Simona Imbriani, Ferdinando Carlo Sasso
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomedicines
Subjects:
metformin
endothelial dysfunction
diabetes
CV risk
Online Access:https://www.mdpi.com/2227-9059/9/1/3

Internet

https://www.mdpi.com/2227-9059/9/1/3

Similar Items